Jett

Too Big to Fail: Now It Gets Interesting

www.infocastinc.com/in...
****** ********Nov. 16 ,USA Bio-Conference Link in Washinton,DC
Major Sponsor

BP is one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items.

It is the largest oil and gas producer in the US and one of the largest refiners.

BP also has a global network of around 22,000 service stations.

Vercipia Biofuels, our joint venture with Verenium, is progressing the development of one of the US's first

commercial-scale cellulosic ethanol facilities, which will produce 36 million gallons of ethanol per year from

energy grasses.


In partnership with DuPont, BP is developing the advanced biofuel biobutanol and constructing a technology demonstration facility in the UK.

Also in the UK, in partnership with British Sugar and DuPont, BP is constructing a 110 million gallon per year wheat-to-ethanol facility

Betting on Natural Gas, Part II: Investing Ideas

www.infocastinc.com/in... Nov. USA Bio-Fuels Conference

Major Sponsor

BP is one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items.

It is the largest oil and gas producer in the US and one of the largest refiners.

BP also has a global network of around 22,000 service stations.

Vercipia Biofuels, our joint venture with Verenium, is progressing the development of one of the US's first

commercial-scale cellulosic ethanol facilities, which will produce 36 million gallons of ethanol per year from

energy grasses.


In partnership with DuPont, BP is developing the advanced biofuel biobutanol and constructing a technology demonstration facility in the UK.

Also in the UK, in partnership with British Sugar and DuPont, BP is constructing a 110 million gallon per year wheat-to-ethanol facility

Nouriel Roubini, One on One: More Doom and Gloom

www.infocastinc.com/in...

Major Sponsor

BP is one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items.

It is the largest oil and gas producer in the US and one of the largest refiners.

BP also has a global network of around 22,000 service stations.

Vercipia Biofuels, our joint venture with Verenium, is progressing the development of one of the US's first

commercial-scale cellulosic ethanol facilities, which will produce 36 million gallons of ethanol per year from

energy grasses.


In partnership with DuPont, BP is developing the advanced biofuel biobutanol and constructing a technology demonstration facility in the UK.

Also in the UK, in partnership with British Sugar and DuPont, BP is constructing a 110 million gallon per year wheat-to-ethanol facility.

Largest Gold Reserves by Country

(VPP), an organization created by the Agenda 2020 Technology Alliance, a special project of the American Forest and Paper Association, and CleanTech Partners, Inc., to test the effectiveness of Verenium's C5 technology for the creation of cellulosic ethanol from the hemicelluloses generated by the pulp and paper process, creating higher value products without negatively impacting paper quality. VPP is funded by the U.S. Department of Energy (DOE), the State of Wisconsin and several large forest products companies.

"We are pleased to be partnering with VPP and enthusiastic for the opportunity to explore the potential of our C5 technology to create biofuels from feedstocks sourced from the pulping process," said Gregory Powers, Executive Vice President of Research and Development of Verenium. "Integrating ethanol production into the pulping process could create an attractive market opportunity for Verenium and the pulping industry. If this project proves successful, Verenium will be well positioned to enable this new source of low-cost biofuels."

How to Invest in Cellulosic Ethanol

Verenium (VRNM)

250 issued patents and more than 350 patent applications.

“Verenium is the first publicly traded, fully-integrated, next-generation

biofuel company.Enable the production of low-cost, biomass derived sugars

for a number of major industrial applications, including the

commercialization of advanced biofuels. Investors include Syngenta, AWM

Investment and Health Care Ventures. Verenium trades under the VRNM

symbol on NASDAQ.Model: The key elements of our corporate strategy are

to develop integrated solutions for the emerging

cellulosic ethanol industry for use in production facilities that we own and

operate, individually or jointly with partners, as well as those of third-party

licensees. We intend to use our leadership position to develop novel,

high-performance enzymes and to advance our technology and process

development capabilities, together

with BP, at our pilot and demonstration-scale plants in Jennings, Louisiana,

our first planned commercial facility in Highlands County, Florida, to exploit

opportunities in the developing market for the production of cellulosic

ethanol. We have established our business model based upon the belief that

owning and managing

cellulosic ethanol production facilities in conjunction with strategic partners, including BP, will allow us to

create economic value by incorporating our scientific and engineering skills

into the production facilities. Through our joint venture with BP, we may also

license our proprietary technology to extend our commercial reach and

accelerate our market penetration.

Past milestones:

1. Verenium begins commissioning nation’s first-of-its kind cellulosic ethanol

demonstration plant in Jennings,

Louisiana;2. Verenium announces plans to build first commercial cellulosic

ethanol plant in Highlands County, Florida,

with a target capacity of up to 36 million gallons per year (MGY);


3. British Petroleum (BP) and Verenium form 50-50 joint venture (JV) to

develop and commercialize cellulosic

ethanol from nonfood feedstocks in the United States; JV now operates

under the name Vercipia Biofuels

Future milestones:

1. Secure financing for first commercial-scale cellulosic ethanol facility in

County, Florida. Vercipia Biofuels, the 50-50 JV company between BP and

, intends to break ground on one of the nation’s first commercial-scale

cellulosic ethanol facilities in Highlands County, Florida, in 2010. This 36

MGY facility is expected to begin commercial production in 2012. Vercipia

developing additional commercial facilities in the Gulf Coast region and

expects to announce the location of its second plant in the coming year.

2. Leverage R&D capabilities and enhance cellulosic ethanol capabilities;

3. Pursue strategic partnership opportunities for the Specialty Enzyme

Business Unit

Verenium’s process technology has also been licensed to Tokyo-based

Marubeni Corporation and Tsukishima Kikai Co., Ltd. and incorporated into

their 1.4 million liter-per-year cellulosic ethanol plant in Osaka, Japan –

utilizing construction and demolition wood waste as a feedstock.

Verenium quotable quotes:

“Verenium is the first publicly traded, fully-integrated, next-generation

biofuel company, and its range of expertise and resources greatly enhances

its potential for success. Verenium is mastering the entire cellulosic ethanol

production process as the first and only company with the full range of “field-

to-pump” capabilities. This includes: growing energy crops, developing

enzymes, processing biomass into fuel and, ultimately, selling it.

, Verenium’s partnerships, which range from industry giants like BP and

to the U.S. Department of Energy (DOE), make the company uniquely

positioned for success.

How to Invest in Cellulosic Ethanol

Subject: Symbol VRNM




Info - for your consideration Good review info :

prnewschannel.com/abso.../...

finance.yahoo.com/news......

finance.yahoo.com/news......

finance.yahoo.com/news......


Greening thru Bio-Mass--BP and Geranium Corporation (Nasdaq: VRNM) today announced.


(BP) British Petroleum(153) Billion Dollar company & Vercipia plans to break

ground on its first commercial plant in Highlands County, Florida in 2010.

For more information on Vercipia, please visit vercipia.com.

On 32,000acres.

Why Verenium? 1. Pioneer in the process since 1995
2. US Patent for their biofuel process
3. Has already sold millions in licenses
4. Has a demo plant in La.
5. Has already received govnt funding
6. Friendly with Chu from the DOE
7. Partnership with BP
8. Building a new plant in Florida with BP
9. Getting a loan guarantee from the DOE
10. Can apply for millions in new grants
11. Govnt offering money to auto manufacturers to produce cars that use renewable energy.
12. Govnt offering money to service stations to add E85 pumps and sell more renewable fuel
13. Govnt has mandated the increased use of cellulosic biofuels starting next year. 15,600% increase by 2022

That its 50-50 joint venture company will operate under the name Vercipia Biofuels, and plan
BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol 7/31/09


BP and Verenium Corporation (Nasdaq: VRNM) today announced that its

50-50 joint venture company will operate under the name Vercipia

Biofuels, and plan to relocate its corporate headquarters to Florida. Vercipia


continues to focus on the development of one of the nation's first

commercial-scale cellulosic ethanol facilities, located in Highlands County,

Florida. The company is also developing a second commercial-scale

cellulosic ethanol site in the Gulf Coast region.

"I continue to be pleased and enthusiastic with the progress our joint

venture - Vercipia - has made in only a few short months, and I look forward

to a highly productive and successful next two years as we move toward

bringing a first commercial facility into production," said Carlos Riva,

President and Chief Executive Officer at Verenium.


"BP's 'all of the above' approach to meeting America's future energy needs

includes a significant investment in biofuels development, as this project

demonstrates," said Susan Ellerbusch, President of BP Biofuels North

America. "We believe Vercipia will be a key player in the biofuels supply

chain in the coming years."


Since announcing the formation of the joint venture company in February,

Vercipia has applied for and been selected to move forward with due

diligence on a Department of Energy (DOE) Loan Guarantee for the

Highlands project, which is now underway. In addition, the team has

continued to advance development activity in Florida and on a second site

in the Gulf Coast region.



BP is of one of the world's largest energy companies, providing its

customers with fuel for transportation, energy for heat and light, retail

services and petrochemicals products for everyday items. It is the largest

oil and gas producer in the U.S. and one of the largest refiners. BP is also a

leading player in the global biofuels market. Since 2006, BP has announced

investments of more than $1.5 billion in biofuels research, development

and operations. This includes partnerships with other companies to

develop the technologies, feedstocks and processes required to produce

advanced biofuels and $500 million over 10 years in the Energy

Biosciences Institute (EBI), at which biotechnologists are investigating

applications of biotechnology to energy.

Closing Update for Thursday, July 30: Firming Up

Andys promised, here's Andy's favorite biofuel play: Verenium (Nasdaq: VRNM).

Andy uncovered Verenium in the June issue of his Government-Driven Investing advisory. Just wait until you see what he dug up in his July issue! This investment could make anyone who listens filthy rich.

The company owns a unique living compound with huge potential in the production of cellulosic ethanol. (Yes, the same market where Verenium is a leader.) Remember, the cellulose space is looking at +15,900% government-mandated growth ahead.

But even that immense market isn't big enough for this company's CEO. He's looking at more than a hundred uses for his patented "C-1 fungus biofactory." C-1 gives him a serious competitive advantage: a patented living organism that no one else can duplicate.

It can help thousands of companies make better bread, better beer, better cosmetics, better drugs, and better gasoline... and only this company has it. He's already licensed this game-changing technology to two major energy producers. Biochemical firm Codexis just paid $10 million to "borrow" this miracle compound.

Who knows how high this stock is headed? I honestly don't. But it's so cheap now that making 100x your
As promised, here's Andy's favorite biofuel play: Verenium (Nasdaq: VRNM).

Andy uncovered Verenium in the June issue of his Government-Driven Investing advisory. Just wait until you see what he dug up in his July issue! This investment could make anyone who listens filthy rich.

The company owns a unique living compound with huge potential in the production of cellulosic ethanol. (Yes, the same market where Verenium is a leader.) Remember, the cellulose space is looking at +15,900% government-mandated growth ahead.

But even that immense market isn't big enough for this company's CEO. He's looking at more than a hundred uses for his patented "C-1 fungus biofactory." C-1 gives him a serious competitive advantage: a patented living organism that no one else can duplicate.

It can help thousands of companies make better bread, better beer, better cosmetics, better drugs, and better gasoline... and only this company has it. He's already licensed this game-changing technology to two major energy producers. Biochemical firm Codexis just paid $10 million to "borrow" this miracle compound.

Who knows how high this stock is headed? I honestly don't. But it's so cheap now that making 100x your money is possible once the technology goes mainstream. It's already a key part of a market forced by law to grow +15,900%.

Do yourself a favor and get the rest of the story here.

P.S. Don't take my word for it. Here's what Andy had to say...

I just got off the phone with one of the most inspiring businessmen I've ever met. He told me a fascinating story involving a wrestler from Iowa, Russian scientists, WWII soldiers and something called "C-1 fungus."

And it all leads to the real possibility of "biofactories" that can turn crops grown anywhere on the planet into all the energy we'll ever want -- eliminating the need for petroleum whatsoever.

I honestly think this guy is going to change the world.

If I'm right, he's going to make bucketloads of money for anyone who comes along for the ride. And that definitely includes me. You're invited too.

Do yourself a favor and get the rest of the story here.

Do yourself a favor and get the rest of the story here.
P.S. Don't take my word for it. Here's what Andy had to say...

I just got off the phone with one of the most inspiring businessmen I've ever met. He told me a fascinating story involving a wrestler from Iowa, Russian scientists, WWII soldiers and something called "C-1 fungus."

And it all leads to the real possibility of "biofactories" that can turn crops grown anywhere on the planet into all the energy we'll ever want -- eliminating the need for petroleum whatsoever.

I honestly think this guy is going to change the world

Closing Update for Thursday, July 30: Firming Up

Andys promised, here's Andy's favorite biofuel play: Verenium (Nasdaq: VRNM).

Andy uncovered Verenium in the June issue of his Government-Driven Investing advisory. Just wait until you see what he dug up in his July issue! This investment could make anyone who listens filthy rich.

The company owns a unique living compound with huge potential in the production of cellulosic ethanol. (Yes, the same market where Verenium is a leader.) Remember, the cellulose space is looking at +15,900% government-mandated growth ahead.

But even that immense market isn't big enough for this company's CEO. He's looking at more than a hundred uses for his patented "C-1 fungus biofactory." C-1 gives him a serious competitive advantage: a patented living organism that no one else can duplicate.

It can help thousands of companies make better bread, better beer, better cosmetics, better drugs, and better gasoline... and only this company has it. He's already licensed this game-changing technology to two major energy producers. Biochemical firm Codexis just paid $10 million to "borrow" this miracle compound.

Who knows how high this stock is headed? I honestly don't. But it's so cheap now that making 100x your
As promised, here's Andy's favorite biofuel play: Verenium (Nasdaq: VRNM).

Andy uncovered Verenium in the June issue of his Government-Driven Investing advisory. Just wait until you see what he dug up in his July issue! This investment could make anyone who listens filthy rich.

The company owns a unique living compound with huge potential in the production of cellulosic ethanol. (Yes, the same market where Verenium is a leader.) Remember, the cellulose space is looking at +15,900% government-mandated growth ahead.

But even that immense market isn't big enough for this company's CEO. He's looking at more than a hundred uses for his patented "C-1 fungus biofactory." C-1 gives him a serious competitive advantage: a patented living organism that no one else can duplicate.

It can help thousands of companies make better bread, better beer, better cosmetics, better drugs, and better gasoline... and only this company has it. He's already licensed this game-changing technology to two major energy producers. Biochemical firm Codexis just paid $10 million to "borrow" this miracle compound.

Who knows how high this stock is headed? I honestly don't. But it's so cheap now that making 100x your money is possible once the technology goes mainstream. It's already a key part of a market forced by law to grow +15,900%.

Do yourself a favor and get the rest of the story here.

P.S. Don't take my word for it. Here's what Andy had to say...

I just got off the phone with one of the most inspiring businessmen I've ever met. He told me a fascinating story involving a wrestler from Iowa, Russian scientists, WWII soldiers and something called "C-1 fungus."

And it all leads to the real possibility of "biofactories" that can turn crops grown anywhere on the planet into all the energy we'll ever want -- eliminating the need for petroleum whatsoever.

I honestly think this guy is going to change the world.

If I'm right, he's going to make bucketloads of money for anyone who comes along for the ride. And that definitely includes me. You're invited too.

Do yourself a favor and get the rest of the story here.

Do yourself a favor and get the rest of the story here.
P.S. Don't take my word for it. Here's what Andy had to say...

I just got off the phone with one of the most inspiring businessmen I've ever met. He told me a fascinating story involving a wrestler from Iowa, Russian scientists, WWII soldiers and something called "C-1 fungus."

And it all leads to the real possibility of "biofactories" that can turn crops grown anywhere on the planet into all the energy we'll ever want -- eliminating the need for petroleum whatsoever.

I honestly think this guy is going to change the world

The Banking Sector Isn't Out of the Woods

Last week's question was "Are you more optimistic about your business now than you were 90 days ago?" Exactly one quarter, 25%, of you replied that yes, you feel more hopeful about the future of your business than you did last quarter. This is a substantial drop from last quarter when just a little over half, 51%, responded positively. These are our lowest numbers in the last six months. We'll see if optimism rebounds or pessimism reigns when we ask this question again in three months.

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

Are you more optimistic about your business now than you were 90 days ago?
This Week 13 Weeks Ago 26 Weeks Ago 39 Weeks Ago 52 Weeks Ago
Yes No Yes No Yes No Yes No Yes No
7 21 46 43 32 20 16 50 24 50
25% 75% 51% 48% 61% 38% 24% 75% 32% 67%

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

The main (economic) event of the week is this Friday – that’s when the Department of Labor releases its June unemployment report. Residential servicers and loan modification experts know full well the corollary between the unemployment rate and mortgage delinquencies. The jobless rate hit a 25-year high of , jumping from 8.9% in April. Will the jobless rate cross the 10% threshold? As for the job market in SoCal, he said that his firm recently advertised for a bi-lingual debt collector. Within three days he received 75 applications for the job...

Lennar Corp. of Miami, the third-largest home builder in the U.S., reported a wider second-quarter loss as sales fell and the company wrote down land it no longer plans to build on.



Delinquencies Rise at Freddie Mac
June 26, 2009

Freddie Mac said loan delinquencies on its portfolio and guarantee book of business rose to 2.01% in May, an 8% uptick from the previous month, but a 229% increase from the same period last year.

The Banking Sector Isn't Out of the Woods

Last week's question was "Are you more optimistic about your business now than you were 90 days ago?" Exactly one quarter, 25%, of you replied that yes, you feel more hopeful about the future of your business than you did last quarter. This is a substantial drop from last quarter when just a little over half, 51%, responded positively. These are our lowest numbers in the last six months. We'll see if optimism rebounds or pessimism reigns when we ask this question again in three months.

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

Are you more optimistic about your business now than you were 90 days ago?
This Week 13 Weeks Ago 26 Weeks Ago 39 Weeks Ago 52 Weeks Ago
Yes No Yes No Yes No Yes No Yes No
7 21 46 43 32 20 16 50 24 50
25% 75% 51% 48% 61% 38% 24% 75% 32% 67%

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

The main (economic) event of the week is this Friday – that’s when the Department of Labor releases its June unemployment report. Residential servicers and loan modification experts know full well the corollary between the unemployment rate and mortgage delinquencies. The jobless rate hit a 25-year high of , jumping from 8.9% in April. Will the jobless rate cross the 10% threshold? As for the job market in SoCal, he said that his firm recently advertised for a bi-lingual debt collector. Within three days he received 75 applications for the job...

Lennar Corp. of Miami, the third-largest home builder in the U.S., reported a wider second-quarter loss as sales fell and the company wrote down land it no longer plans to build on.



Delinquencies Rise at Freddie Mac
June 26, 2009

Freddie Mac said loan delinquencies on its portfolio and guarantee book of business rose to 2.01% in May, an 8% uptick from the previous month, but a 229% increase from the same period last year.

The Banking Sector Isn't Out of the Woods

This guy know how to talk...and make real use of Youtube...

walstreetpro2.blogspot.../
Click Here

The Banking Sector Isn't Out of the Woods

This is a financial coup d etat orchestrated by Wall ST in conjunction with the U.S. treasury to consolidate power

into the hands of the people that caused the problem in the first place, such as JP Morgan Chase (originator of

credit derivatives) and Goldman Sachs

Alt A and Option Arm loans-reset-the entire recovery-based on accounting fraud

Alt A and Option Arm loans will reset soon. And don't forget the entire recovery has been based on accounting

fraud- namely credit value adjustments.

The Top 25 Global Banks by Assets

ADELPHI, Md. (AP) -- Government experts called for sweeping safety restrictions Tuesday on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet.
The Food and Drug Administration assembled 37 experts to recommend ways to reduce deadly overdoses with acetaminophen, which is the leading cause of liver failure in the U.S. and sends 56,000 people to the emergency room annually. About 200 die each year.

"We're here because there are inadvertent overdoses with this drug that are fatal and this is the one opportunity we have to do something that will have a big impact," said Dr. Judith Kramer of Duke University Medical Center.

But over-the-counter cold medicines -- such as Nyquil and Theraflu -- that combine other drugs with acetaminophen can stay on the market, the panel said, rejecting a proposal to take them off store shelves.

The FDA is not required to follow the advice of its panels, though it usually does. The agency gave no indication when it would act on the recommendations.

In a series of votes Tuesday, the panel recommended 21-16 to lower the maximum dose of over-the-counter acetaminophen from 4 grams, or eight pills of a medication such as Extra Strength Tylenol. They did not specify how much it should be lowered.

The panel also endorsed limiting the maximum single dose of the drug to 650 milligrams. That would be down from the 1,000-milligram dose, or two tablets of Extra Strength Tylenol.

A majority of panelists also said the 1,000-milligram dose should only be available by prescription.

The industry group that represents Johnson & Johnson, Wyeth and other companies defended the current dosing that appears on over-the-counter products.

"I think it's a very useful dose and one that is needed for treating chronic pain, such as people with chronic osteoarthritis," said Linda Suydam, president of the Consumer Healthcare Products Association.

The experts narrowly ruled that prescription drugs that combine acetaminophen with other painkilling ingredients should be eliminated. They cited FDA data indicating that 60 percent of acetaminophen-related deaths are related to prescription products.

But some on the panel opposed a sweeping withdraw of products that are widely used to control severe, chronic pain. Prescription acetaminophen combination drugs were prescribed 200 million times last year, according to the FDA.

"To make this shift without very clear understanding of the implications on the management of pain would be a huge mistake," said Dr. Robert Kerns of Yale University.

If the drugs stay on the market, they should carry a black box warning, the most serious safety label available, the panel decided.

"If we don't eliminate the combination products we should at least lower the levels of acetaminophen contained in those medicines," said Sandra Kewder, FDA's deputy director for new drugs, summarizing the panel's vote.

Percocet and similar treatments combine acetaminophen with more powerful pain relieving narcotics, such as oxycodone.

If the combination products are eliminated, the acetaminophen and the other ingredients could be prescribed separately. In effect, patients would take two pills instead of one, and be more aware of the acetaminophen they are consuming.

Vicodin is marketed by Abbott Laboratories, while Percocet is marketed by Endo Pharmaceuticals. Both painkillers also are available in cheaper generic versions.

"The panel recommending banning Vicodin and Percocet seems a little draconian," said Les Funtleyder, an analyst for Miller Tabak & Co.

Drug companies avoided the most damaging potential outcome with the defeat of proposal to pull NyQuil and other over-the-counter cold and cough medicines that combine acetaminophen with other drugs.

These drugs can be dangerous when taken with Tylenol or other drugs containing acetaminophen, according to the FDA, but cause only 10 percent of acetaminophen-related deaths.

"I don't think we should be advocating a solution to a problem that really is not there," said Dr. Osemwota Omoigui, of the Los Angeles pain clinic.

A recall of combination cold medicines would have cost manufacturers hundreds of millions of dollars in revenue. Total sales of all acetaminophen drugs reached $2.6 billion last year, with 80 percent of the market comprised of over-the-counter products, according to IMS Health, a health care analysis firm.

"The acetaminophen people dodged a bullet," said Erik Gordon, a University of Michigan business professor who studies the biomedical industry.

Even with the lower daily dosage recommendation, consumers will likely keep taking as many pills as they think they need to ease their pain, Gordon said.

Analyst Steve Brozak of WBB Securities said the panel votes were a "shot across the bow" of the pharmaceutical industry.

"This basically puts more government oversight into something that heretofore has been less than present," Brozak said.

AP Business writers Stephen Manning and Donna Borak contributed to this report.

The Top 25 Global Banks by Assets

This is a financial coup d etat orchestrated by Wall ST in conjunction with the U.S. treasury to consolidate power

into the hands of the people that caused the problem in the first place, such as JP Morgan Chase (originator of

credit derivatives) and Goldman Sachs

Alt A and Option Arm loans-reset-the entire recovery-based on accounting fraud

Alt A and Option Arm loans will reset soon. And don't forget the entire recovery has been based on accounting

fraud- namely credit value adjustments.

The Top 25 Global Banks by Assets

Last week's question was "Are you more optimistic about your business now than you were 90 days ago?" Exactly one quarter, 25%, of you replied that yes, you feel more hopeful about the future of your business than you did last quarter. This is a substantial drop from last quarter when just a little over half, 51%, responded positively. These are our lowest numbers in the last six months. We'll see if optimism rebounds or pessimism reigns when we ask this question again in three months.

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

Are you more optimistic about your business now than you were 90 days ago?
This Week 13 Weeks Ago 26 Weeks Ago 39 Weeks Ago 52 Weeks Ago
Yes No Yes No Yes No Yes No Yes No
7 21 46 43 32 20 16 50 24 50
25% 75% 51% 48% 61% 38% 24% 75% 32% 67%

This week's question is "Has your company increased its marketing spending in the past 90 days?" As always, we'd love to hear what you think. Be sure to give us your input by clicking on the survey form on the left-hand side.

The main (economic) event of the week is this Friday – that’s when the Department of Labor releases its June unemployment report. Residential servicers and loan modification experts know full well the corollary between the unemployment rate and mortgage delinquencies. The jobless rate hit a 25-year high of , jumping from 8.9% in April. Will the jobless rate cross the 10% threshold? As for the job market in SoCal, he said that his firm recently advertised for a bi-lingual debt collector. Within three days he received 75 applications for the job...

Lennar Corp. of Miami, the third-largest home builder in the U.S., reported a wider second-quarter loss as sales fell and the company wrote down land it no longer plans to build on.



Delinquencies Rise at Freddie Mac
June 26, 2009

Freddie Mac said loan delinquencies on its portfolio and guarantee book of business rose to 2.01% in May, an 8% uptick from the previous month, but a 229% increase from the same period last year.